What does SLS stand for?
new york, march 31, 2022 (globe newswire) -- sellas life sciences group, inc. (nasdaq: sls) (“sellas” or the “company”), a late-stage clinical biopharmaceutical company focused on the development...
Is Sellas Life Sciences Group Inc (SLS) stock a good buy?
Apr 14, 2022 · SLS SELLAS Life Sciences Group — Stock Price and Discussion | Stocktwits. SELLAS Life Sciences Group NASDAQ Updated Apr 22, 2022 11:12 PM. SLS 3.02 0.02 (0.66%) Post-Market 0.12 (3.97%) 41,992. Key Data. 52wk Low 2.94.
How often are SLS stock predictions updated?
Apr 20, 2022 · SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of immunotherapeutic for cancer indications. The firm's product...
Where can I buy shares of SLS?
Apr 01, 2022 · SELLAS Life Sciences Group's stock was trading at $2.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SLS shares have increased by 41.1% and is now trading at $3.02. View which stocks have been most impacted by COVID-19.
Is SLS a good stock to buy?
SELLAS Life Sciences Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
What happened to Sellas Life Sciences stock?
SELLAS Life Sciences Stock Plunges After $25M Capital Raise Via Equity, In-Licenses Cancer-Focused CDK9 Inhibitor.Apr 1, 2022
Will SLS go up?
Given the current short-term trend, the stock is expected to rise 16.87% during the next 3 months and, with a 90% probability hold a price between $6.13 and $8.43 at the end of this 3-month period.
How do you buy stocks on wish?
Shares of WISH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What is the current status of the SLS?
As of April 2022, the first launch is scheduled for no earlier than August 2022, pending the success of a wet dress rehearsal test.
Is SELLAS Life Sciences Group a buy right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SELLAS Life Sciences Group in the last twelve months. There are currently...
How has SELLAS Life Sciences Group's stock price been impacted by Coronavirus?
SELLAS Life Sciences Group's stock was trading at $2.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health...
When is SELLAS Life Sciences Group's next earnings date?
SELLAS Life Sciences Group is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022. View our earnings forecas...
How were SELLAS Life Sciences Group's earnings last quarter?
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) released its quarterly earnings results on Friday, November, 12th. The company reported ($0.45) earni...
When did SELLAS Life Sciences Group's stock split? How did SELLAS Life Sciences Group's stock split work?
SELLAS Life Sciences Group shares reverse split on Friday, November 8th 2019. The 1-50 reverse split was announced on Wednesday, November 6th 2019....
What price target have analysts set for SLS?
4 analysts have issued 1-year price objectives for SELLAS Life Sciences Group's shares. Their forecasts range from $16.00 to $21.00. On average, th...
Who are SELLAS Life Sciences Group's key executives?
SELLAS Life Sciences Group's management team includes the following people: Angelos M. Stergiou , President, Chief Executive Officer & Director J...
Who are some of SELLAS Life Sciences Group's key competitors?
Some companies that are related to SELLAS Life Sciences Group include Enochian Biosciences (ENOB) , Akebia Therapeutics (AKBA) , Avadel Pharmace...
What is SELLAS Life Sciences Group's stock symbol?
SELLAS Life Sciences Group trades on the NASDAQ under the ticker symbol "SLS."
3.5 Analyst's Opinion
Is SELLAS Life Sciences Group a buy right now?
SELLAS Life Sciences Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
How has SELLAS Life Sciences Group's stock been impacted by Coronavirus (COVID-19)?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SELLAS Life Sciences Group in the last twelve months. There are currently 4 buy ratings for the stock.
When is SELLAS Life Sciences Group's next earnings date?
SELLAS Life Sciences Group's stock was trading at $2.14 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SLS stock has increased by 174.3% and is now trading at $5.87. View which stocks have been most impacted by COVID-19.
How were SELLAS Life Sciences Group's earnings last quarter?
SELLAS Life Sciences Group is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022. View our earnings forecast for SELLAS Life Sciences Group.
When did SELLAS Life Sciences Group's stock split? How did SELLAS Life Sciences Group's stock split work?
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) posted its quarterly earnings results on Friday, November, 12th. The company reported ($0.45) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.09. View SELLAS Life Sciences Group's earnings history.
What price target have analysts set for SLS?
Shares of SELLAS Life Sciences Group reverse split on the morning of Friday, November 8th 2019. The 1-50 reverse split was announced on Wednesday, November 6th 2019. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 7th 2019.
Signals & Forecast
4 brokers have issued twelve-month target prices for SELLAS Life Sciences Group's stock. Their forecasts range from $16.00 to $21.00. On average, they anticipate SELLAS Life Sciences Group's share price to reach $17.88 in the next twelve months.
Support, Risk & Stop-loss
The SELLAS Life Sciences Group Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is SELLAS Life Sciences Group Inc. stock A Buy?
On the downside, the stock finds support just below today's level from accumulated volume at $5.39 and $4.80. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, SELLAS Life Sciences Group Inc.
Insiders are very positive buying more shares than they are selling in SELLAS Life Sciences Group Inc
SELLAS Life Sciences Group Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 5.88 million shares bought and 1.55 million shares sold. The last trade was done 21 days ago by Burns John Thomas who bough 36 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
SLS Stock Benefits From Recent GLSI Gains
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
News Comes Tomorrow
As mentioned above, the runs in SLS are the result of a sympathy play. It all started after Greenwich LifeSciences stock ran nearly 1,000% in a single day. Those gains were driven by a strong poster presentation given at a prestigious cancer meeting.
What Is Sellas Life Sciences?
Remember, GLSI stock gained nearly 1,000% in a single day after presenting data at a cancer meeting. Moreover, that data was nothing new, but investors didn’t care.
Analyst Opinions of SLS Stock
SELLAS Life Sciences Group is a clinical-stage biotechnology company looking to produce therapeutic options for some of the world’s most debilitating cancers.
Risks to Consider Before Buying SLS
According to TipRanks, one analyst covers Sellas Life Sciences stock, rating it a Buy with a price target of $8. That’s a strong price target, representing a potential upside of more than 25%.
Final Thoughts
Any time you buy a stock, you’re accepting the risks that come along with that investment, and every investment comes with risk. An investment in SLS stock is no different. Here are the most significant risks to consider before buying SLS:
Is Solaris Resources (TSE:SLS) In A Good Position To Invest In Growth?
Something is brewing in SLS stock, and based on everything mentioned above, I believe that it’s poised for dramatic gains. With a presentation tomorrow at the same meeting that sent GLSI screaming for the top, there’s a huge opportunity to consider here.
Solaris Announces Significant New Discovery at Warintza South
Just because a business does not make any money, does not mean that the stock will go down. For example, Solaris...
